Cortecs diagnostics/imaging, drug delivery, infectious diseases news

CCS reached a settlement with founder and former executive chairman Glen Travers (see BioCentury, June 15, 1998). Travers will receive a gross payment of £1.3 million (US$2.1 million)-representing sal...